+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Canada Pacemaker Market, By Region, Competition, Forecast & Opportunities, 2020-2030F

  • PDF Icon

    Report

  • 88 Pages
  • May 2025
  • Region: Canada
  • TechSci Research
  • ID: 5877563
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Canada Pacemaker Market was valued at USD 405.10 Million in 2024, and is expected to reach USD 512.36 Million by 2030, rising at a CAGR of 3.99%. This growth is primarily driven by a rising incidence of cardiovascular diseases and increasing healthcare costs associated with cardiac conditions in the country. Supportive government initiatives are enhancing access to healthcare services, while innovation in pacemaker technology - such as the introduction of MRI-safe and leadless devices - is fostering market expansion. Additionally, medical device companies are offering these advanced products within reimbursement frameworks, further boosting demand. The focus on producing high-end, patient-specific pacemakers is expected to sustain market momentum. Notably, in 2020, heart disease and stroke together accounted for more fatalities in Canada than COVID-19, highlighting the critical need for cardiac interventions.

Key Market Drivers

Aging Population and Rising Cardiovascular Disease Prevalence

Canada’s population is aging, with those aged 65 and above making up 19% in 2022, a figure expected to reach 22.5% by 2030. This demographic shift is closely linked to a higher prevalence of cardiovascular diseases, which significantly increases the demand for pacemakers to manage heart rhythm disorders. Around 2.6 million adults in Canada - about 1 in 12 - have been diagnosed with heart disease, highlighting the growing need for reliable cardiac care solutions like pacemakers.

Key Market Challenges

High Costs and Economic Barriers

Although pacemaker therapy offers essential benefits, the associated expenses for devices and surgical procedures remain a major hurdle. While Canada’s public healthcare system covers many medical costs, provincial differences in reimbursement policies often create inconsistencies. Patients may incur additional costs, especially for newer pacemaker technologies not yet included in standard formularies, creating accessibility issues - particularly for low-income individuals or those in areas with limited healthcare coverage.

Key Market Trends

Technological Advancements in Pacemaker Devices

Canada's pacemaker market is advancing through continuous technological innovation focused on improving device performance and patient outcomes. Developments such as leadless pacemakers reduce infection risks and simplify implantation, while MRI-compatible models allow safer diagnostic imaging. Furthermore, features like wireless connectivity and remote monitoring enable healthcare professionals to oversee device function and patient health in real-time, enhancing care delivery and operational efficiency in clinical settings.

Key Market Players

  • Medtronic of Canada Ltd
  • Abbott Medical Canada Inc
  • Biotronik Canada Inc
  • LivaNova Canada
  • Microport Scientific Corporation
  • Spectramedx Inc.

Report Scope:

In this report, the Canada Pacemaker market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Canada Pacemaker Market, By Type:

  • Implantable
  • External

Canada Pacemaker Market, By Technology:

  • Dual Chamber
  • Single Chamber
  • Biventricular Chamber

Canada Pacemaker Market, By Product Type:

  • MRI Compatible
  • Conventional

Canada Pacemaker Market, By Application:

  • Arrhythmias
  • Congestive Heart Failure
  • Others

Canada Pacemaker Market, By End User:

  • Hospitals
  • Cardiac Care Centers
  • Ambulatory Surgical Centers

Canada Pacemaker Market, By Region:

  • Ontario
  • Quebec
  • Alberta
  • British Columbia
  • Saskatchewan and Manitoba
  • Rest of Canada

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Canada Pacemaker Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report.

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Canada Pacemaker Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Implantable and External)
5.2.2. By Technology (Dual Chamber, Single Chamber, Biventricular Chamber)
5.2.3. By Product Type (MRI Compatible and Conventional)
5.2.4. By Application (Arrythmias, Congestive Heart Failure, Others)
5.2.5. By End User (Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers) (Natural/Organic Pacemaker v/s Processed Pacemaker)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. Ontario Pacemaker Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Technology
6.2.3. By Product Type
6.2.4. By Application
6.2.5. By End User
7. Quebec Pacemaker Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Technology
7.2.3. By Product Type
7.2.4. By Application
7.2.5. By End User
8. Alberta Pacemaker Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Technology
8.2.3. By Product Type
8.2.4. By Application
8.2.5. By End User
9. British Columbia Pacemaker Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Technology
9.2.3. By Product Type
9.2.4. By Application
9.2.5. By End User
10. Saskatchewan and Manitoba Pacemaker Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Technology
10.2.3. By Product Type
10.2.4. By Application
10.2.5. By End User
11. Rest of Canada Pacemaker Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Type
11.2.2. By Technology
11.2.3. By Product Type
11.2.4. By Application
11.2.5. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
13.1. Merger & Acquisition (If Any)
13.2. Product Launches (If Any)
13.3. Recent Developments
14. Porters Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products/Services
15. Competitive Landscape
15.1. Medtronic of Canada Ltd
15.1.1. Business Overview
15.1.2. Company Snapshot
15.1.3. Products & Services
15.1.4. Financials (As Reported)
15.1.5. Recent Developments
15.1.6. Key Personnel Details
15.1.7. SWOT Analysis
15.2. Abbott Medical Canada Inc
15.3. Biotronik Canada Inc
15.4. LivaNova Canada
15.5. Microport Scientific Corporation
15.6. Spectramedx Inc.
16. Strategic Recommendations17. About the Publisher & Disclaimer

Companies Mentioned

  • Medtronic of Canada Ltd
  • Abbott Medical Canada Inc
  • Biotronik Canada Inc
  • LivaNova Canada
  • Microport Scientific Corporation
  • Spectramedx Inc.

Table Information